▶ 調査レポート

世界のレナリドマイド市場:専門的調査

• 英文タイトル:Global Lenalidomide Market Professional Survey Report 2019

QYResearchが調査・発行した産業分析レポートです。世界のレナリドマイド市場:専門的調査 / Global Lenalidomide Market Professional Survey Report 2019 / QYR9ST08443資料のイメージです。• レポートコード:QYR9ST08443
• 出版社/出版日:QYResearch / 2019年9月5日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥518,000 (USD3,500)▷ お問い合わせ
  Enterprise License¥1,036,000 (USD7,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートは、レナリドマイドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、5 mgカプセル、10 mgカプセル、15 mgカプセル、25 mgカプセルに、用途別には、多発性骨髄腫(MM)、骨髄異形成症候群(MDS)にセグメント区分し、レナリドマイドの世界市場を分析しました。


・エグゼクティブ・サマリー
・レナリドマイドの世界市場概要
・レナリドマイドの製造コスト構成分析
・レナリドマイドの開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・レナリドマイドの地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・レナリドマイドのセグメント分析(種類別)
(5 mgカプセル、10 mgカプセル、15 mgカプセル、25 mgカプセル)
・レナリドマイドのセグメント分析(用途別)
(多発性骨髄腫(MM)、骨髄異形成症候群(MDS))
・レナリドマイドの主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Celgene、SL Pharma)
・レナリドマイドの市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...

The global Lenalidomide market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Lenalidomide volume and value at global level, regional level and company level. From a global perspective, this report represents overall Lenalidomide market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Lenalidomide in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Lenalidomide manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Celgene
SL Pharma

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
5 mg Capsules
10 mg Capsules
15 mg Capsules
25 mg Capsules

Segment by Application
Multiple myeloma (MM)
Myelodysplastic syndromes (MDS)

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Lenalidomide
1.1 Definition of Lenalidomide
1.2 Lenalidomide Segment by Type
1.2.1 Global Lenalidomide Production Growth Rate Comparison by Types (2014-2025)
1.2.2 5 mg Capsules
1.2.3 10 mg Capsules
1.2.4 15 mg Capsules
1.2.5 25 mg Capsules
1.3 Lenalidomide Segment by Applications
1.3.1 Global Lenalidomide Consumption Comparison by Applications (2014-2025)
1.3.2 Multiple myeloma (MM)
1.3.3 Myelodysplastic syndromes (MDS)
1.4 Global Lenalidomide Overall Market
1.4.1 Global Lenalidomide Revenue (2014-2025)
1.4.2 Global Lenalidomide Production (2014-2025)
1.4.3 North America Lenalidomide Status and Prospect (2014-2025)
1.4.4 Europe Lenalidomide Status and Prospect (2014-2025)
1.4.5 China Lenalidomide Status and Prospect (2014-2025)
1.4.6 Japan Lenalidomide Status and Prospect (2014-2025)
1.4.7 Southeast Asia Lenalidomide Status and Prospect (2014-2025)
1.4.8 India Lenalidomide Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Lenalidomide
2.3 Manufacturing Process Analysis of Lenalidomide
2.4 Industry Chain Structure of Lenalidomide

3 Development and Manufacturing Plants Analysis of Lenalidomide
3.1 Capacity and Commercial Production Date
3.2 Global Lenalidomide Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Lenalidomide
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Lenalidomide Production and Capacity Analysis
4.2 Lenalidomide Revenue Analysis
4.3 Lenalidomide Price Analysis
4.4 Market Concentration Degree

5 Lenalidomide Regional Market Analysis
5.1 Lenalidomide Production by Regions
5.1.1 Global Lenalidomide Production by Regions
5.1.2 Global Lenalidomide Revenue by Regions
5.2 Lenalidomide Consumption by Regions
5.3 North America Lenalidomide Market Analysis
5.3.1 North America Lenalidomide Production
5.3.2 North America Lenalidomide Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Lenalidomide Import and Export
5.4 Europe Lenalidomide Market Analysis
5.4.1 Europe Lenalidomide Production
5.4.2 Europe Lenalidomide Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Lenalidomide Import and Export
5.5 China Lenalidomide Market Analysis
5.5.1 China Lenalidomide Production
5.5.2 China Lenalidomide Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Lenalidomide Import and Export
5.6 Japan Lenalidomide Market Analysis
5.6.1 Japan Lenalidomide Production
5.6.2 Japan Lenalidomide Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Lenalidomide Import and Export
5.7 Southeast Asia Lenalidomide Market Analysis
5.7.1 Southeast Asia Lenalidomide Production
5.7.2 Southeast Asia Lenalidomide Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Lenalidomide Import and Export
5.8 India Lenalidomide Market Analysis
5.8.1 India Lenalidomide Production
5.8.2 India Lenalidomide Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Lenalidomide Import and Export

6 Lenalidomide Segment Market Analysis (by Type)
6.1 Global Lenalidomide Production by Type
6.2 Global Lenalidomide Revenue by Type
6.3 Lenalidomide Price by Type

7 Lenalidomide Segment Market Analysis (by Application)
7.1 Global Lenalidomide Consumption by Application
7.2 Global Lenalidomide Consumption Market Share by Application (2014-2019)

8 Lenalidomide Major Manufacturers Analysis
8.1 Celgene
8.1.1 Celgene Lenalidomide Production Sites and Area Served
8.1.2 Celgene Product Introduction, Application and Specification
8.1.3 Celgene Lenalidomide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 SL Pharma
8.2.1 SL Pharma Lenalidomide Production Sites and Area Served
8.2.2 SL Pharma Product Introduction, Application and Specification
8.2.3 SL Pharma Lenalidomide Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served

9 Development Trend of Analysis of Lenalidomide Market
9.1 Global Lenalidomide Market Trend Analysis
9.1.1 Global Lenalidomide Market Size (Volume and Value) Forecast 2019-2025
9.2 Lenalidomide Regional Market Trend
9.2.1 North America Lenalidomide Forecast 2019-2025
9.2.2 Europe Lenalidomide Forecast 2019-2025
9.2.3 China Lenalidomide Forecast 2019-2025
9.2.4 Japan Lenalidomide Forecast 2019-2025
9.2.5 Southeast Asia Lenalidomide Forecast 2019-2025
9.2.6 India Lenalidomide Forecast 2019-2025
9.3 Lenalidomide Market Trend (Product Type)
9.4 Lenalidomide Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Lenalidomide Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Lenalidomide
Table Global Lenalidomide Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Lenalidomide Production Market Share by Types in 2018
Figure 5 mg Capsules Product Picture
Figure 10 mg Capsules Product Picture
Figure 15 mg Capsules Product Picture
Figure 25 mg Capsules Product Picture
Table Global Lenalidomide Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Lenalidomide Consumption Market Share by Applications in 2018
Figure Multiple myeloma (MM)
Figure Myelodysplastic syndromes (MDS)
Figure Global Lenalidomide Revenue (Million USD) (2014-2025)
Figure Global Lenalidomide Production (K Pcs) (2014-2025)
Figure North America Lenalidomide Market Size (Million USD) (2014-2025)
Figure Europe Lenalidomide Market Size (Million USD) (2014-2025)
Figure China Lenalidomide Market Size (Million USD) (2014-2025)
Figure Japan Lenalidomide Market Size (Million USD) (2014-2025)
Figure Southeast Asia Lenalidomide Market Size (Million USD) (2014-2025)
Figure India Lenalidomide Market Size (Million USD) (2014-2025)
Table Lenalidomide Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Lenalidomide in 2018
Figure Manufacturing Process Analysis of Lenalidomide
Figure Industry Chain Structure of Lenalidomide
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Lenalidomide Manufacturing Plants Distribution
Table Lenalidomide Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Lenalidomide Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Lenalidomide Production (K Pcs) of Major Manufacturers (2014-2019)
Table Lenalidomide Production Market Share of Major Manufacturers (2014-2019)
Figure Lenalidomide Production Share by Manufacturers in 2018
Table Lenalidomide Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Lenalidomide Revenue Market Share of Major Manufacturers (2014-2019)
Figure Lenalidomide Revenue Share by Manufacturers in 2018
Table Lenalidomide Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Lenalidomide Production by Regions 2014-2019 (K Pcs)
Table Global Lenalidomide Production Market Share by Regions 2014-2019
Figure Global Lenalidomide Production Market Share by Regions in 2018
Table Global Lenalidomide Revenue by Regions 2014-2019 (Million USD)
Table Global Lenalidomide Revenue Market Share by Regions 2014-2019
Figure Global Lenalidomide Revenue Market Share by Regions in 2018
Table Global Lenalidomide Consumption by Regions 2014-2019 (K Pcs)
Table Global Lenalidomide Consumption Market Share by Regions 2014-2019
Figure North America Lenalidomide Production Growth Rate 2014-2019 (K Pcs)
Figure North America Lenalidomide Revenue Growth Rate 2014-2019 (Million USD)
Table North America Lenalidomide Production, Consumption Import and Export (K Pcs)
Figure Europe Lenalidomide Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Lenalidomide Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Lenalidomide Production, Consumption Import and Export (K Pcs)
Figure China Lenalidomide Production Growth Rate 2014-2019 (K Pcs)
Figure China Lenalidomide Revenue Growth Rate 2014-2019 (Million USD)
Table China Lenalidomide Production, Consumption Import and Export (K Pcs)
Figure Japan Lenalidomide Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Lenalidomide Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Lenalidomide Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Lenalidomide Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Lenalidomide Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Lenalidomide Production, Consumption Import and Export (K Pcs)
Figure India Lenalidomide Production Growth Rate 2014-2019 (K Pcs)
Figure India Lenalidomide Revenue Growth Rate 2014-2019 (Million USD)
Table India Lenalidomide Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Lenalidomide Market Share by Application (2014-2019)
Figure Global Value (Consumption) Lenalidomide Market Share by Application (2014-2019)
Table Celgene Lenalidomide Production Sites and Area Served
Table Celgene Lenalidomide Product Introduction, Application and Specification
Table Celgene Lenalidomide Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celgene Lenalidomide Production Growth Rate (2014-2019)
Table Celgene Lenalidomide Production Market Share (2014-2019)
Figure Celgene Lenalidomide Revenue Market Share (2014-2019)
Table Celgene Lenalidomide Main Business and Markets Served
Table SL Pharma Lenalidomide Production Sites and Area Served
Table SL Pharma Lenalidomide Product Introduction, Application and Specification
Table SL Pharma Lenalidomide Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table SL Pharma Lenalidomide Production Growth Rate (2014-2019)
Table SL Pharma Lenalidomide Production Market Share (2014-2019)
Figure SL Pharma Lenalidomide Revenue Market Share (2014-2019)
Table SL Pharma Lenalidomide Main Business and Markets Served
Figure Global Lenalidomide Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Lenalidomide Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Lenalidomide Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Lenalidomide Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Lenalidomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Lenalidomide Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Lenalidomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Lenalidomide Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Lenalidomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Lenalidomide Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Lenalidomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Lenalidomide Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Lenalidomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Lenalidomide Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Lenalidomide Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Lenalidomide by Type (2019-2025)
Table Global Consumption (K Pcs) of Lenalidomide by Application (2019-2025)
Table Lenalidomide Distributors List
Table Lenalidomide Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources